FDA 510(k) FDA class 2 Substantially Equivalent 🇨🇦 Canada

SEKURE Creatine Kinase Assay

K Number: K182702 · Decision Apr 17, 2019
Classifications
1
FEI Numbers
25
Registration Numbers
25
Same Product Code
122
Applicant Total
6
Review Days
202

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
SEKURE Creatine Kinase Assay
K Number
K182702
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
862.1215
Medical Specialty
Clinical Chemistry
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Sekisui Diagnostics P.E.I., Inc.
Date Received
September 27, 2018
Decision Date
April 17, 2019
Product Code
CGS
Advisory Committee
Clinical Chemistry
Review Advisory Committee
CH
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
CGS Nad Reduction/Nadh Oxidation, Cpk Or Isoenzymes

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (CGS), ordered by most recent decision date.

View all

Other Clearances by Sekisui Diagnostics P.E.I., Inc.

K Number Device Name
K202644 Acetaminophen
K180835 SEKURE Acetaminophen L3K Assay
K173206 SEKURE HbA1c Assay
K163078 DC-UIBC-CAL
K111915 MAGNESIUM ASSAY